Loading ...

A Screening Study for Identification of Tolerance Markers in Liver Transplant Recipients Who Received Campath-1H Immunosuppression

(

)

ITN Protocol #:

ITN816AS

Branded Name:

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Complete

Summary:

A Screening Study for Identification of Tolerance Markers in Liver Transplant Recipients Who Received Campath-1H Immunosuppression

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Anil Chandrakerachandraker@rics.bwh.harvard.edu

Work: 

617-525-8208

Protocol Chair

Kenneth Newell, MD PhDkanewel@emory.edu

Work: 

404-727-2489

Protocol Chair

Larry Turkalturka@bidmc.harvard.edu

Work: 

617-735-2919

Protocol Chair

Michele DesMaraismdesmarais@immunetolerance.org

Work: 

415-420-4250

Protocol Chair

Nadia Tchaontchao@immunetolerance.org

Work: 

415-353-4414

Protocol Chair

Yvonne Morrison, MSyvonne.morrison@nih.gov

Work: 

240-627-3577

Protocol Chair

David Ikle, PhDDavid_Ikle@rhoworld.com

Work: 

919-595-6378

Protocol Chair

Lauren Sherwoodlauren_sherwood@rhoworld.com

Work: 

919-595-6367